GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » IMBdx Inc (XKRX:461030) » Definitions » Inventories, Raw Materials & Components

IMBdx (XKRX:461030) Inventories, Raw Materials & Components : ₩468 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is IMBdx Inventories, Raw Materials & Components?

IMBdx's inventories, raw materials & components for the quarter that ended in Dec. 2024 was ₩468 Mil.

IMBdx's quarterly raw materials declined from Jun. 2024 (₩561 Mil) to Sep. 2024 (₩540 Mil) and declined from Sep. 2024 (₩540 Mil) to Dec. 2024 (₩468 Mil).

IMBdx's annual raw materials declined from Dec. 2022 (₩529 Mil) to Dec. 2023 (₩242 Mil) but then increased from Dec. 2023 (₩242 Mil) to Dec. 2024 (₩468 Mil).


IMBdx Inventories, Raw Materials & Components Historical Data

The historical data trend for IMBdx's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IMBdx Inventories, Raw Materials & Components Chart

IMBdx Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Inventories, Raw Materials & Components
- 528.94 241.81 468.30

IMBdx Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only 241.81 361.67 560.78 540.00 468.30

IMBdx Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.


IMBdx Business Description

Industry
Traded in Other Exchanges
N/A
Address
131 Gasandigital 1-ro, 21st Floor BYC Highcity Building A, Geumcheon-gu, Seoul, KOR, 08506
IMBdx Inc detects and analyzes the genomic profile of tumor DNA with a single draw of blood. It provides personalized and optimized analysis information that can be utilized in therapy selection and monitoring. Its AlphaLiquid platform offers ctDNA-based precision diagnostics solutions across the full continuum of cancer care, from therapy selection (AlphaLiquid 100/HRR) to recurrence and minimal residual disease(MRD) monitoring (CancerDetect), and multi-cancer early detection (CancerFind). Its services are Clinical Service BioPharma, Research, and Healthcare Checkup.

IMBdx Headlines

No Headlines